Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)
China · Delayed Price · Currency is CNY 12.48
+0.50 (4.17%)
Jun 23, 2026, 3:00 PM CST
SHA:688488 Market Cap
SHA:688488 has a market cap or net worth of 5.04 billion as of June 23, 2026. Its market cap has increased by 0.42% in one year.
Market Cap
5.04B
Enterprise Value
5.34B
Revenue
699.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.48
Market Cap Chart
Since July 20, 2020, SHA:688488's market cap has decreased from 12.99B to 5.04B, a decrease of -61.18%. That is a compound annual growth rate of -14.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 5.04B | -26.64% |
| Dec 31, 2025 | 6.87B | 107.76% |
| Dec 31, 2024 | 3.31B | -37.17% |
| Dec 29, 2023 | 5.26B | 18.91% |
| Dec 30, 2022 | 4.43B | -32.31% |
| Dec 31, 2021 | 6.54B | -37.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai OPM Biosciences | 5.30B |
| Anhui Huaheng Biotechnology | 5.24B |
| Hangzhou Biotest Biotech | 5.18B |
| Novogene | 5.06B |
| Shenzhen Weiguang Biological Products | 5.03B |
| Shanghai Serum Bio-Technology | 4.86B |
| PharmaResources (Shanghai) | 4.84B |
| Zhejiang Wecome Pharmaceutical Company | 4.79B |